Gene therapy strategies to facilitate organ transplantation

被引:10
作者
Deng, SP [1 ]
Brayman, KL
机构
[1] Univ Western Ontario, London Hlth Sci Ctr, Multiorgan Transplant Serv, London, ON N6G 5A5, Canada
[2] Univ Penn, Sch Med, Dept Surg, Pancreas & Human Islet Transplnatat Program, Philadelphia, PA 19104 USA
来源
MOLECULAR MEDICINE TODAY | 1999年 / 5卷 / 09期
关键词
D O I
10.1016/S1357-4310(99)01543-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Organ transplantation is now the definitive therapy for many forms of end-organ disease, but chronic allograft rejection, the side effects of chronic immunosuppressive therapy and the severe donor organ shortage continue to limit its success. Gene therapy has the potential to prevent graft rejection by manipulating the immune response in the microenvironment of the graft or by facilitating the induction of tolerance, Genetic manipulation of stem cells to create transgenic and/or knockout animals that could serve as organ or cell donors could be combined with gene therapy approaches to overcome the problem of limited allogeneic donor organ supply.
引用
收藏
页码:400 / 405
页数:6
相关论文
共 46 条
[1]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[2]   Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B [J].
Anrather, J ;
Csizmadia, V ;
Brostjan, C ;
Soares, MP ;
Bach, FH ;
Winkler, H .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) :763-772
[3]   Genetic engineering as an approach to xenotransplantation [J].
Bach, FH .
WORLD JOURNAL OF SURGERY, 1997, 21 (09) :913-916
[4]   Accommodation of vascularized xenografts: Expression of ''protective genes'' by donor endothelial cells in a host Th2 cytokine environment [J].
Bach, FH ;
Ferran, C ;
Hechenleitner, P ;
Mark, W ;
Koyamada, N ;
Miyatake, T ;
Winkler, H ;
Badrichani, A ;
Candinas, D ;
Hancock, WW .
NATURE MEDICINE, 1997, 3 (02) :196-204
[5]   Delayed xenograft rejection [J].
Bach, FH ;
Winkler, H ;
Ferran, C ;
Hancock, WW ;
Robson, SC .
IMMUNOLOGY TODAY, 1996, 17 (08) :379-384
[6]   Inhibition of xenoreactive natural antibody production by retroviral gene therapy [J].
Bracy, JL ;
Sachs, DH ;
Iacomini, J .
SCIENCE, 1998, 281 (5384) :1845-1847
[7]   Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo [J].
Cheng, L ;
Mantile, G ;
Pauly, R ;
Nater, C ;
Felici, A ;
Monticone, R ;
Bilato, C ;
Gluzband, YA ;
Crow, MT ;
Stetler-Stevenson, W ;
Capogrossi, MC .
CIRCULATION, 1998, 98 (20) :2195-2201
[8]   IL-10 and TGF-beta gene transfer for xenogeneic islet transplantation: Comparison of effect in concordant vs discordant combination [J].
Deng, S ;
Ketchum, RJ ;
Kucher, T ;
Weber, M ;
Shaked, A ;
Naji, A ;
Brayman, KL .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (04) :2204-2205
[9]  
Deng S., 1997, Acta Diabetologica, V34, P115
[10]  
DENG S, 1994, TRANSPLANT P, V26, P1184